Cited by 292Pancreatic and Hepatic Oncology ResearchCancer, Hypoxia, and MetabolismCancer, Lipids, and Metabolism

Neurons release serine to support mRNA translation in pancreatic cancer

Open access
Banh, Robert S., Biancur, Douglas E., Yamamoto, Keisuke, Sohn, Albert S.W., Walters, Beth, Kuljanin, Miljan, Gikandi, Ajami, Wang, Huamin +4 more·2020·Cell

Abstract

Pancreatic ductal adenocarcinoma (PDAC) tumors have a nutrient-poor, desmoplastic, and highly innervated tumor microenvironment. Although neurons can release stimulatory factors to accelerate PDAC tumorigenesis, the metabolic contribution of peripheral axons has not been explored. We found that peripheral axons release serine (Ser) to support the growth of exogenous Ser (exSer)-dependent PDAC cells during Ser/Gly (glycine) deprivation. Ser deprivation resulted in ribosomal stalling on two of the six Ser codons, TCC and TCT, and allowed the selective translation and secretion of nerve growth factor (NGF) by PDAC cells to promote tumor innervation. Consistent with this, exSer-dependent PDAC tumors grew slower and displayed enhanced innervation in mice on a Ser/Gly-free diet. Blockade of compensatory neuronal innervation using LOXO-101, a Trk-NGF inhibitor, further decreased PDAC tumor growth. Our data indicate that axonal-cancer metabolic crosstalk is a critical adaptation to support PDAC growth in nutrient poor environments.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2020.10.016

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Neural invasion is a well-recognized feature of pancreatic tumors, and its severity negatively correlates with prognosis.

    “Neural invasion is a well-recognized feature of pancreatic tumors, with the severity negatively correlating to prognosis262.”

    From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [262]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 86 · Cited by 292

Authors
Banh, R. S., Biancur, D. E., Yamamoto, K., Sohn, A. S. W., Walters, B., Kuljanin, M., Gikandi, A., Wang, H., Mancias, J. D., Schneider, R. J., Pacold, M. E., & Kimmelman, A. C.
Affiliations
  • NYU Langone Health (US)
  • Dana-Farber Cancer Institute (US)
  • The University of Texas MD Anderson Cancer Center (US)
Corresponding author
Kimmelman, Alec C.
Venue
Cell
Publisher
Elsevier BV
Published
2020-11
Volume
183
Issue
5
Pages
1202-1218.e25
ISSN
0092-8674 (ISSN-L)
OpenAlex
W3096366814
Cited by
292
References
86
Citations by year
2026: 58 · 2025: 64 · 2024: 43 · 2023: 47 · 2022: 46 · 2021: 29 · 2020: 5
FWCI
11.47
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • V Foundation for Cancer Research (V2017-004)
  • National Institute of General Medical Sciences (R01GM095567)
  • American Cancer Society (RSG-13-298-01-TBG)
  • Breast Cancer Research Foundation (BCRF-16-143)
  • Damon Runyon Cancer Research Foundation (F99 CA245822, T32 CA009161, DRG-2348-18)
  • Mary Kay Foundation (017-32)
  • Burroughs Wellcome Fund
  • National Cancer Institute (P30CA016087, F99 CA245822, T32 CA009161, PH719)
  • Uehara Memorial Foundation
  • Lustgarten Foundation
  • Stanford Genome Technology Center
  • Stand Up To Cancer
  • National Institutes of Health (T32 CA9161-41)
  • Hearst Foundations
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords
pancreatic ductal adenocarcinoma, serine, tumor innervation, mRNA translation, ribosome stalling, nerve growth factor, tumor microenvironment
MeSH terms
Adenocarcinoma, Aged, Animals, Axons, Codon, Female, Glycine, Humans, Male, Middle Aged, Mitochondria, Nerve Tissue, Neurons, Oxygen Consumption, Pancreatic Neoplasms, Pyrazoles, Pyrimidines, RNA, Messenger, RNA, Transfer, Serine, Protein Biosynthesis, Carcinoma, Pancreatic Ductal, Cell Line, Tumor, Cell Proliferation, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review